Skip to main content

Headlines

AZN : Phase III Trial Of FASENRA In Eosinophilic Granulomatosis With Polyangiitis Meets Main Goal
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Crinetics : Phase 3 Study Of Paltusotine In Acromegaly Meets Primary And Secondary Endpoints
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Amgen Reports Positive Data From Phase 1 Study Of Lumakras Combination In Non-small Cell Lung Cancer
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Valneva Reports Positive Pediatric & Adolescent Phase 2 Booster Results For Lyme Disease Vaccine
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Tonix Pharma Reports Topline Results From Phase 2 PREVAIL Proof-of-Concept Study Of TNX-102 SL
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Genmab : Phase 3 Trial Of TIVDAK In Recurrent Or Metastatic Cervical Cancer Meets Primary Endpoint
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Genmab, Seagen say phase three of innovaTV 301 trial met primary endpoint
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Genentech : Phase III Study Of Alecensa In ALK-Positive Early-Stage Lung Cancer Meets Main Goal
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
VettaFi’s Dave Nadig on AI: "We Should Be in That Critical Learning Phase"
posted:
by: Nasdaq ETFs
#channels:: #All, #Business, #Nasdaq, #NasdaqETFs, #ETFs, #Stocks
Novocure : Phase 3 Trial In Platinum-resistant Ovarian Cancer Fails To Meet Main Goal; Stock Plunges
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Amgen : Olpasiran Phase 2 Data Shows Continued Reduction Of Lp(a) Nearly A Year After Last Dose
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
GSK Plc Reports 100% Vaccine Efficacy From Post-license Phase IV Trial Of Shingrix In China
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Genentech Issues Update On Phase III SKYSCRAPER-01 Study - Quick Facts
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Exelixis, Ipsen Reports Positive Phase 3 CONTACT-02 Study Data In Prostate Cancer
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
HUTCHMED : Sovleplenib Phase III ESLIM-01 Study Meets Main Goal In Primary Immune Thrombocytopenia
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets